Expression of Cell-Cycle Mediators in Ovarian Cancer Cells after Transfection with p16INK4a, p21WAF1/Cip-1, and p53

This publication has 20 references indexed in Scilit:

• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Adenovirus-Mediated p53 Growth Inhibition of Ovarian Cancer Cells Is Independent of Endogenous p53 Status
  Gynecologic Oncology, 1999
• Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21WAF1/CIP1 and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity
  Oncogene, 1999
• Studies on the molecular mechanism of growth inhibition with p53 adenoviral construct in human ovarian cancer
  International Journal of Gynecologic Cancer, 1998
• Growth Inhibition of Human Cervical Cancer Cells with the Recombinant Adenovirusp53 in Vitro
  Gynecologic Oncology, 1996
• Adenovirus-Based p53 Gene Therapy in Ovarian Cancer
  Gynecologic Oncology, 1995
• Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.
  Genes & Development, 1994
• Stable Expression of the Wild-Typep53Gene in Human Lung Cancer Cells after Retrovirus-Mediated Gene Transfer
  Human Gene Therapy, 1993
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
  Cell, 1992
• Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation
  Cell, 1989